MedPath

BRIAN ANDERSON MD

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Ketamine-assisted Therapy for Advanced GI Cancer

Phase 4
Terminated
Conditions
Pancreatic Ductal Adenocarcinoma
Pain, Acute
Gastrointestinal Cancers
Demoralization
Interventions
Behavioral: Meaning and Purpose therapy
Other: Placebo
Other: Questionnaires
First Posted Date
2023-10-11
Last Posted Date
2025-05-21
Lead Sponsor
Brian Anderson, MD
Target Recruit Count
1
Registration Number
NCT06077487
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath